News

Genome Institute of Singapore and Roche announce collaboration on development of SARS detection kit

May 22 2003 - Genome Institute of Singapore and Roche Diagnostics announced an agreement to co-develop a Severe Acute Respiratory Syndrome (SARS) detection kit based on one of Roche's platform technologies - Polymerase Chain Reaction (PCR) technology. SARS is a respiratory infection, caused by a new strain of coronavirus, that has recently been reported in a number of regions, including Singapore. Since its outbreak in March, the Genome Institute of Singapore has been working to sequence the genetic code of the SARS coronavirus and has defined its genetic diversity. This information is critical to the development of robust diagnostic assays.


The diagnostic kit is expected to be ready... Please click here for the full news release.

For archive news, Please click here for news release.

Useful Links